relative to treatment alternatives to opioids.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 10 Sponsors 3

Nov 10, 2025 · House

Committee Report: Ought to Pass with Amendment # 2025-2990h (NT) 10/28/2025 (Vote 17-0; CC)

Oct 8, 2025 · House

Executive Session: 10/28/2025 11:00 am GP 229

Sep 22, 2025 · House

Full Committee Work Session: 10/08/2025 10:00 am GP 229

Aug 27, 2025 · House

Full Committee Work Session: 09/10/2025 10:00 am GP 229

Mar 5, 2025 · House

Retained in Committee

Feb 20, 2025 · House

Subcommittee Work Session: 03/04/2025 10:00 am LOB 104

Feb 13, 2025 · House

Executive Session: 03/05/2025 10:00 am LOB 302-304

Jan 15, 2025 · House

Public Hearing: 01/23/2025 01:45 pm LOB 302-304

Jan 9, 2025 · House

Vacated and Referred to Commerce and Consumer Affairs (Rep. W. MacDonald): MA VV (in recess of) 01/09/2025 HJ 3 P. 7

Jan 7, 2025 · House

Introduced 01/08/2025 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 12

PASSAGE PROBABILITY

38.9% Uncertain

Why this number

Stage base Reported from Committee — base rate 47%, measured from NH's completed sessions
Momentum -0 49/100 from the pace of recorded action
Time since last action -22 334 days quiet
Cosponsors +3 2 signed on
Bipartisan support +9 2 D · 1 R
Sponsor influence +2 71/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.